21.09.2015 Views

The Wales FH Cascade Testing Initiative Dr Ian McDowell

FH in Wales Ian McDowell - Heart UK

FH in Wales Ian McDowell - Heart UK

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>The</strong> <strong>Wales</strong> <strong>FH</strong> <strong>Cascade</strong> <strong>Testing</strong> <strong>Initiative</strong><br />

<strong>Dr</strong> <strong>Ian</strong> <strong>McDowell</strong>


<strong>FH</strong> is common<br />

• ~ 110,000 in UK<br />

• ~ 6,000 in <strong>Wales</strong><br />


<strong>Wales</strong> <strong>FH</strong> Special Interest Group<br />

British Soc<br />

Human Genetics<br />

<strong>FH</strong> RCP audit<br />

CV IRG<br />

NICE <strong>FH</strong><br />

Guideline<br />

Cardiac Networks<br />

& CHD NSF<br />

Welsh<br />

Cardiovascular Society<br />

BHF<br />

Welsh Cardiac<br />

Rehab Nursing<br />

Welsh Endo<br />

& Diabetes<br />

Soc / WEDS<br />

LDL Apheresis<br />

Service<br />

SSAGCC&<br />

Welsh Chemical<br />

Path Group<br />

CESAGEN<br />

<strong>Wales</strong> <strong>FH</strong><br />

Special Interest Group<br />

Dutch<br />

<strong>FH</strong> project<br />

Public Heath<br />

Paediatrics<br />

BIMDG<br />

Clinical<br />

GeneticsAWMGS<br />

All <strong>Wales</strong> Medicines<br />

Advisory Group<br />

Molecular<br />

Genetics<br />

<strong>FH</strong> Patient<br />

Forum<br />

<strong>Wales</strong> Gene<br />

Park<br />

Genetic<br />

Interest Group<br />

HEART UK


<strong>FH</strong> <strong>Cascade</strong> Projects in <strong>Wales</strong><br />

<strong>FH</strong> nurse<br />

Bridgend/Cardiff<br />

<strong>FH</strong><br />

Patient Forum<br />

<strong>FH</strong><br />

projects<br />

Genotyping<br />

<strong>FH</strong><br />

<strong>Cascade</strong> Software


Cardiff - Bridgend<br />

<strong>Cascade</strong> <strong>Testing</strong> Pilot


<strong>FH</strong> <strong>Cascade</strong> Software


National Screening<br />

Program Familial<br />

Hypercholesterolemia<br />

Peter Lansberg<br />

Stichting Opsporing Familiaire Hypercholesterolemie (StOEH)


Dutch database<br />

• Dutch national screening programme for <strong>FH</strong><br />

• Over 45,000 family members<br />

• 18,000 diagnosed with <strong>FH</strong>.<br />

• Database: Pass Clinical<br />

• <strong>Wales</strong> clinical pilot of database<br />

• commenced 2009


Key Features<br />

1. Pedigree drawing function<br />

2. Workflow management<br />

3. Templates and archiving<br />

4. Multisite working<br />

5. Audit and research


Conclusions<br />

• <strong>The</strong> Dutch wheel works well in the UK setting<br />

• Essential for <strong>FH</strong> cascade testing<br />

• Could be adapted for other conditions


Patient Pathway with <strong>Cascade</strong> <strong>Testing</strong><br />

???<strong>FH</strong><br />

General<br />

Practice<br />

??<strong>FH</strong><br />

Hospital<br />

(eg Cardiology)<br />

Family <strong>Cascade</strong> Programme<br />

•Full Pedigree<br />

•Family registration<br />

•Family Tracing<br />

•Test 1 st degree relatives<br />

Lipid Clinic<br />

Clinical and lipid assessment Provisional<br />

diagnosis of <strong>FH</strong> using SB criteria<br />

Genotype<br />

positive<br />

<strong>Cascade</strong> from<br />

relatives<br />

<strong>FH</strong> ü<br />

<strong>FH</strong> X<br />

Document family history<br />

Genotyping<br />

Treat hyperlipidaemia<br />

Consultation to<br />

advise on <strong>FH</strong><br />

treatment<br />

options<br />

<strong>FH</strong><br />

diagnosed<br />

Referred to<br />

lipid clinic<br />

<strong>FH</strong> excluded<br />

in relative<br />

Discharged from cascade<br />

programme:<br />

Continuing care<br />

Primary care (most)<br />

Continuing care<br />

Secondary care(some)<br />

Continuing care<br />

Paediatrics (some)


Welsh Assembly Government<br />

Cardiff and Vale NHS Trust<br />

Cardiac Networks for <strong>Wales</strong><br />

Clinical Director<br />

All <strong>Wales</strong> Genetic<br />

Service<br />

<strong>FH</strong> professional steering group<br />

AWGS Lead<br />

genetic counsellor<br />

<strong>FH</strong> Project Manager<br />

Senior Nurse<br />

manager<br />

Data base & project<br />

administrator<br />

<strong>FH</strong> nurse<br />

(M&SW)<br />

<strong>FH</strong> genetic<br />

counsellor<br />

(S)<br />

<strong>FH</strong> nurse<br />

(SE)<br />

<strong>FH</strong> genetic<br />

counsellor<br />

(N)<br />

<strong>FH</strong> nurse<br />

(N)


Scoring Criteria for patients with possible Familial Hypercholesterolaemia<br />

Please note these criteria only apply for index cases, not famil y members of known genotype<br />

positive patients.<br />

Family<br />

History<br />

Physical<br />

Examination<br />

Lipid<br />

Lowering<br />

Treatment<br />

Untreated or<br />

corrected<br />

LDL-<br />

Cholesterol<br />

Concentrations<br />

(mmol/l)<br />

Fasting<br />

Triglycerides<br />

(mmol/l)<br />

•First degree relative (FDR) known with premature ( 5mmol/l<br />

•FDR with tendon xanthomata and/or corneal arcus (< 45yrs)<br />

•FDR ( 3.5mmol/l<br />

•Tendon xanthomata<br />

•Corneal arcus (< 45yrs)<br />

•Is patient on lipid lowering treatment? YES / NO<br />

oIf NO, go to Untreated LDL- Cholesterol Concentrations<br />

oIf YES, give details ……………………………………<br />

If untreated LDL-C values are unobtainable see attached sheet (Correction Factor Table)<br />

and calculate estimated value.<br />

•LDL-C > 8.5<br />

•LDL-C 6.5 – 8.4<br />

•LDL-C 5.0 – 6.4<br />

•LDL-C 4.0 – 4.9<br />

•Tg 2.5 – 3.5<br />

•Tg 3.5 – 5<br />

•Tg > 5<br />

Points<br />

minus 2<br />

minus 3<br />

minus 4<br />

Proband eligibility for <strong>FH</strong> genotyping is based on total points score<br />

Only one score from each box<br />

>8 usually eligible for genotyping<br />

6-8 eligible if funding available<br />

5 or less usually not unless exceptional circumstances<br />

Forms which are unclear, incomplete or not eligible for genotyping will be returned to the requesting clinician<br />

and the sample stored for X months for possible future use.<br />

1<br />

1<br />

2<br />

2<br />

6<br />

4<br />

8<br />

5<br />

3<br />

1


Familial<br />

hypercholesterolaemia<br />

Implementing NICE guidance<br />

2008<br />

NICE clinical guideline 71


<strong>FH</strong> <strong>Cascade</strong> Programme for <strong>Wales</strong><br />

Partnership BHF and WAG<br />

• BHF fund 3 <strong>FH</strong> nurses for 3 years<br />

• WAG other aspects+ continuation


Implementation Phases<br />

• Phase 1<br />

• Project manager<br />

• Patient pathway<br />

details<br />

• Genotyping<br />

• Software procurement<br />

• Phase 2<br />

• Nurses and GC<br />

appointments<br />

• Education<br />

• Paediatric services<br />

• Full roll out


Thank You!

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!